Xeris Biopharma Holdings, Inc. (XERS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.26B |
| Enterprise Value | 1.19B |
| P/E Ratio | 117.8 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 4.57 |
| Price/Book Ratio | 109.3 |
| Enterprise/Revenue | 4.34 |
| Enterprise/EBITDA | 29.6 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 7.35 |
Income Statement
| Revenue | 291.85M |
| Revenue/Share | 1.85 |
| Gross Profit | 238.43M |
| EBITDA | 12.71M |
| Net Income | 554,000 |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 111.75M |
| Total Cash/Share | 0.66 |
| Total Debt | 37.33M |
| Total Debt/Equity | 2.87 |
| Current Ratio | 2.12 |
| Book Value Per Share | 0.08 |
Price History
| 52-Week Change | 53.31 |
| 52-Week High | 10.08 |
| 52-Week Low | 4.87 |
| Moving Average 50 Days | 6.8 |
| Moving Average 200 Days | 7.06 |
Statistics
| Average Volume | 1.86M |
| Shares Outstanding | 172.64M |
| % Held by Institutions | 65.58 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
